Health Care Counsel Blog
852 total results. Page 10 of 35.
Take note, all providers who received Provider Review Fund (PRF) payments – there are changes in the reporting deadlines and requirements.
On March 31, 2021, New York Governor Andrew Cuomo signed the Marijuana Regulation and Taxation Act (MRTA) into law, legalizing adult-use cannabis in the state and establishing a regulatory framework to govern what likely will be one of the nation’s largest cannabis markets.
In July 2020, the Trump Administration issued an Executive Order (the EO) directing the Secretary of the Department of Health and Human Services (HHS) to take certain actions and finalize rulemakings designed to “support the goal of safe importation of prescription drugs.”
Los Angeles Partner Debra Albin-Riley recently argued before the California Supreme Court in a closely-watched case involving the scope of anti-SLAPP protection for medical staff peer review.
Health Care Partner Stephanie Trunk is presenting twice at the Informa Medicaid & Government Pricing Congress June 8-11, 2021.
The Minnesota Department of Health (MDH) will host a public, virtual meeting on Thursday, June 10, 2021, at 1 p.m. Central time to present and request feedback on draft reporting guidelines for the Minnesota Prescription Drug Price Transparency Act (Minnesota Statutes 62.J.84).
Join Arent Fox Partner Anne Murphy as she moderates a panel on Emerging Governance Issues for health care organizations.
On May 21, 2021, SavaSeniorCare LLC and several of its affiliates, which own and operate skilled nursing facilities across the country, agreed to pay $11.2 million to resolve claims that the companies billed Medicare for rehabilitation therapy services that were not reasonable or necessary.
Health Care Partner Debra Albin-Riley and Counsel Sarah Benator will present a webinar for the California Society for Healthcare Attorneys (CSHA) on May 26, 2021.
Similar to the laws of several other states, the North Dakota law contains three main disclosure requirements that apply to “drug manufacturers”
Several recent surveys and reports by governance and trade associations provide a useful overview of the duties, roles, challenges, and internal relationships of the corporate general counsel, as well as governing board needs and priorities.
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries
Congress recently passed two bills that are designed to educate patients and prescribers about biosimilars and thereby encourage their use and to close a loophole in existing law that allows certain branded drugs to retain longer market exclusivity.
Headlines that Matter for Companies and Executives in Regulated Industries.
On Thursday, the Senate Finance Committee held a confirmation hearing for two of the most important health policy officials nominated by President Biden, Chiquita Brooks-LaSure (Administrator, Centers for Medicare and Medicaid Services) and Andrea Palm (Deputy Secretary).
Headlines that Matter for Companies and Executives in Regulated Industries
Hospitals everywhere in the United States should take note: CMS announced on March 26, 2020, that it is lifting its extended 30-day survey suspension for hospitals. Survey activity will now resume.
In recent years, the emergency medical services (EMS) sector has assumed a more central role in health care delivery, including care in the home and, in some cases, emergency department visit prevention.
Headlines that Matter for Companies and Executives in Regulated Industries
Texas Health and Human Services announced that beginning April 1, 2021, drug manufacturers who wish for their products to be added to the Texas Drug Code Index (the Texas Medicaid formulary) must create an electronic account.
Applicable drug manufacturers and group purchasing organizations that are subject to the reporting rules under the Open Payments System are reminded that March 31, 2021, is the final day to submit and attest to data for the June 2021 publication of Program Year 2020 data.
Immediately at issue was Lilly and Company and Lilly USA’ refusal to sell covered outpatient drugs at the 340B Ceiling Price to contract pharmacies acting as agents for 340B Covered Entities. Several 340B Covered Entities had petition for a hearing by the ADR panel.
Headlines that Matter for Companies and Executives in Regulated Industries
The American Rescue Plan Act of 2021, signed into law by President Biden on March 11, 2021, is a $1.9 trillion aid package that provides assistance to businesses and individuals experiencing financial hardship due to COVID-19.